Stenabolic (SR-9009) 10
$80.00
Iron Ascension Stenabolic 10 (SR-9009) is a specialized REV-ERBa agonist engineered to enhance metabolic rate, boost aerobic capacity, and accelerate lipid oxidation. By directly activating REV-ERB proteins within skeletal muscle and metabolic tissues, it stimulates mitochondrial biogenesis, turns off fat-storing genes, and enhances VO2 max and physical stamina without impacting the central nervous system or endocrine system.
Guaranteed safe checkout
Description
Description
Iron Ascension Stenabolic (SR-9009) 10
Specifications & Composition
| Specification | Details |
|---|---|
| Active Compound | SR-9009 (Stenabolic) |
| Concentration | 10 mg per tablet |
| Total Quantity | 60 tablets |
| Delivery System | Oral administration |
| Formulation Standard | Pharmaceutical grade (manufacturer claim; verification required) |
| Batch Testing | High-Performance Liquid Chromatography (HPLC), as reported |
Key Research Features
- REV-ERB Receptor Activity: SR-9009 is an experimental compound studied for its interaction with REV-ERB nuclear receptors, which are involved in circadian regulation and metabolic gene expression.
- Mitochondrial and Energy Metabolism: Animal research has investigated potential changes in mitochondrial activity and energy metabolism. Claims of increased mitochondrial density or fatigue resistance in humans remain unproven.
- Lipid Metabolism and Exercise Capacity: Preclinical studies have explored possible effects on lipid metabolism and physical activity. Reliable improvements in human fat loss, aerobic capacity, or athletic performance have not been established.
Important Safety & Evidence Considerations
SR-9009 remains an investigational research compound and is not an approved medication or established human performance-enhancement treatment. Human pharmacokinetics, oral bioavailability, effective exposure, long-term safety, and potential adverse effects are not adequately characterized.
The stated tablet strength should not be interpreted as a validated human dose. Claims of non-stimulant fat loss, enhanced oxygen utilization, or improved endurance should be treated as unproven rather than established product benefits.
Quality Control & Lab Verification
| Quality Parameter | Reported Result |
|---|---|
| Compound | SR-9009 (oral tablets) |
| Assay Result | 99.7% active compound (reported) |
| Testing Method | HPLC (reported) |
| Verification Status | PASSED (manufacturer-reported) |
Product Identity Correction
The product heading identifies SR-9009, while the supplied quality-control description also identifies SR-9009, but the product name contains the spelling “Stenabolic.” Confirm that the intended compound is SR-9009 before publication and ensure all packaging and laboratory documentation use the same identity.
Publication note: Verify chemical identity, 10 mg per tablet strength, 99.7% assay result, pharmaceutical-grade designation, and batch-specific HPLC certificate of analysis. HPLC assay alone does not establish tablet uniformity, dissolution, contaminant absence, oral bioavailability, or clinical safety. Do not imply regulatory approval or suitability for human consumption.
Specifications
- Short Stroke Gas Piston Gas System (Rifle Length)
- 18.6″ Barrel Length ( Mid-Weight style, non-fluted)
- 1:8 Twist Rate Rifling
Reviews
There are no reviews yet.